264 related articles for article (PubMed ID: 17576460)
1. Single-agent interleukin-2 in the treatment of metastatic melanoma.
Petrella T; Quirt I; Verma S; Haynes AE; Charette M; Bak K;
Curr Oncol; 2007 Feb; 14(1):21-6. PubMed ID: 17576460
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide for the treatment of metastatic melanoma.
Quirbt I; Verma S; Petrella T; Bak K; Charette M;
Curr Oncol; 2007 Feb; 14(1):27-33. PubMed ID: 17576461
[TBL] [Abstract][Full Text] [Related]
3. Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline.
Verma S; Petrella T; Hamm C; Bak K; Charette M;
Curr Oncol; 2008 Apr; 15(2):85-9. PubMed ID: 18454183
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline.
Verma S; Younus J; Stys-Norman D; Haynes AE; Blackstein M
Curr Oncol; 2007 Aug; 14(4):144-8. PubMed ID: 17710206
[TBL] [Abstract][Full Text] [Related]
5. Management of single brain metastasis: a practice guideline.
Mintz A; Perry J; Spithoff K; Chambers A; Laperriere N
Curr Oncol; 2007 Aug; 14(4):131-43. PubMed ID: 17710205
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline.
Reece D; Imrie K; Stevens A; Smith CA;
Curr Oncol; 2006 Oct; 13(5):160-72. PubMed ID: 22792013
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.
Cripps C; Winquist E; Devries MC; Stys-Norman D; Gilbert R;
Curr Oncol; 2010 Jun; 17(3):37-48. PubMed ID: 20567625
[TBL] [Abstract][Full Text] [Related]
8. Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer.
Jonker D; Rumble RB; Maroun J;
Curr Oncol; 2006 Oct; 13(5):173-84. PubMed ID: 22792014
[TBL] [Abstract][Full Text] [Related]
9. Alemtuzumab in chronic lymphocytic leukemia.
Fraser G; Smith CA; Imrie K; Meyer R;
Curr Oncol; 2007 Jun; 14(3):96-109. PubMed ID: 17593982
[TBL] [Abstract][Full Text] [Related]
10. Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline.
Verma S; Younus J; Haynes AE; Stys-Norman D; Blackstein M;
Curr Oncol; 2008 Apr; 15(2):80-4. PubMed ID: 18454188
[TBL] [Abstract][Full Text] [Related]
11. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
12. Treatment of metastatic malignant melanoma.
Atallah E; Flaherty L
Curr Treat Options Oncol; 2005 May; 6(3):185-93. PubMed ID: 15869730
[TBL] [Abstract][Full Text] [Related]
13. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
Rusthoven J; Bramwell V; Stephenson B
Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
[TBL] [Abstract][Full Text] [Related]
14. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
Brundage MD; Crook JM; Lukka H
Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
[TBL] [Abstract][Full Text] [Related]
15. Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review.
Petrella T; Quirt I; Verma S; Haynes AE; Charette M; Bak K;
Cancer Treat Rev; 2007 Aug; 33(5):484-96. PubMed ID: 17562357
[TBL] [Abstract][Full Text] [Related]
16. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
[TBL] [Abstract][Full Text] [Related]
17. Locoregional therapy of locally advanced breast cancer: a clinical practice guideline.
Brackstone M; Fletcher GG; Dayes IS; Madarnas Y; SenGupta SK; Verma S;
Curr Oncol; 2015 Mar; 22(Suppl 1):S54-66. PubMed ID: 25848339
[TBL] [Abstract][Full Text] [Related]
18. Systemic adjuvant therapy for adult patients at high risk for recurrent cutaneous or mucosal melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline.
Petrella TM; Fletcher GG; Knight G; McWhirter E; Rajagopal S; Song X; Baetz TD
Curr Oncol; 2020 Feb; 27(1):e43-e52. PubMed ID: 32218667
[TBL] [Abstract][Full Text] [Related]
19. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
Serrone L; Zeuli M; Sega FM; Cognetti F
J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
